TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Biorega AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
147
|
271
|
21 |
| Financial expenses |
18
|
0
|
1 |
| Earnings before taxes |
846
|
2,953
|
-7 |
| EBITDA |
-19
|
-93
|
-6 |
| Total assets |
2,775
|
3,732
|
931 |
| Current assets |
2,532
|
3,732
|
129 |
| Current liabilities |
49
|
297
|
442 |
| Equity capital |
2,713
|
3,427
|
484 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
97.8%
|
91.8%
|
52.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
575.5%
|
1089.7%
|
-33.3% |
| Return on assets (ROA) |
31.1%
|
79.1%
|
-0.6% |
| Current ratio |
5167.3%
|
1256.6%
|
29.2% |
| Return on equity (ROE) |
31.2%
|
86.2%
|
-1.4% |
| Change turnover |
-116
|
251
|
21 |
| Change turnover % |
-44%
|
1203% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.